Your browser doesn't support javascript.
loading
Evaluation of the efficacy of a therapeutic HIV vaccine by in vitro stimulation assay.
He, Xiaozhou; Wang, Wandi; Xu, Ke; Feng, Xia; Zeng, Yi.
Affiliation
  • He X; State Key Laboratory of Infectious Disease Prevention and Control, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100052, China.
  • Wang W; State Key Laboratory of Infectious Disease Prevention and Control, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100052, China.
  • Xu K; State Key Laboratory of Infectious Disease Prevention and Control, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100052, China.
  • Feng X; State Key Laboratory of Infectious Disease Prevention and Control, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100052, China. Electronic address: fengxia621@126.com.
  • Zeng Y; State Key Laboratory of Infectious Disease Prevention and Control, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100052, China. Electronic address: zengyicdc@sina.com.
Cell Immunol ; 313: 67-71, 2017 03.
Article de En | MEDLINE | ID: mdl-28073435

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Lymphocytes T / Infections à VIH / VIH-1 (Virus de l'Immunodéficience Humaine de type 1) / Vaccins contre le SIDA / Immunothérapie Type d'étude: Evaluation_studies Limites: Adolescent / Adult / Female / Humans / Male / Middle aged Pays/Région comme sujet: Asia Langue: En Journal: Cell Immunol Année: 2017 Type de document: Article Pays d'affiliation: Chine Pays de publication: Pays-Bas

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Lymphocytes T / Infections à VIH / VIH-1 (Virus de l'Immunodéficience Humaine de type 1) / Vaccins contre le SIDA / Immunothérapie Type d'étude: Evaluation_studies Limites: Adolescent / Adult / Female / Humans / Male / Middle aged Pays/Région comme sujet: Asia Langue: En Journal: Cell Immunol Année: 2017 Type de document: Article Pays d'affiliation: Chine Pays de publication: Pays-Bas